Atlas Trials

Careseng 1370 for Chemotherapy-Induced Myelosuppression

Clinical trial NCT03692780 · WITHDRAWN

Trial details

NCT number
NCT03692780
Sponsor
Careseng Biotech Co., Ltd.
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Chemotherapy-Induced Myelosuppression
Start date
2019-03-01
Primary completion
2021-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.